Management of cervical cancer

European Journal of Surgical Oncology

Volumn 32, Issue 8, 2006, Pages 832-837

  Kesic, V ^a  

^a CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Cervical cancer; Management

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN;

AGE; ARTICLE; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; CLINICAL EXAMINATION; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE REGIMEN; FEMALE; FEMALE FERTILITY; GASTROINTESTINAL TOXICITY; HEMATOLOGIC DISEASE; HUMAN; INDIVIDUALIZATION; LAPAROSCOPIC SURGERY; LYMPH NODE METASTASIS; MEDICAL DECISION MAKING; MEDICAL LITERATURE; METASTASIS POTENTIAL; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN PRESERVATION; PELVIS LYMPHADENECTOMY; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; RECURRENT CANCER; SENSITIVITY AND SPECIFICITY; STANDARDIZATION; UTERINE CERVIX CANCER; UTERINE CERVIX CONIZATION; VAGINAL HYSTERECTOMY;

EID: 33749127881     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.03.037     Document Type: Article

References (42)

1. Pecorelli S., Beller U., Heintz P.A., Benedet L.J., Creasman W.T., and Peterson F. The 25th FIGO Annual Report on the Results of Treatment in Gynecologic Cancer. Int J Gynaecol Obstet 83 Suppl. 1 (2003) 1-229
2. Lai C.H., Huang K.G., See L.C., et al. Restaging of recurrent cervical carcinoma with dual-phase [18F]fluoro-2-deoxy-D-glucose positron emission tomography. Cancer 100 (2004) 544-552
3. Sonoda Y., Leblanc E., Querleu D., et al. Prospective evaluation of surgical staging of advanced cervical cancer via a laparoscopic extraperitoneal approach. Gynecol Oncol 91 (2003) 326-331
4. Vergote I., Amant F., Berteloot P., and Van Gramberen M. Laparoscopic lower para-aortic staging lymphadenectomy in stage Ib2 and III cervical cancer. Int J Gynecol Cancer 12 (2002) 22-26
5. Lai C.H., Huang K.G., Hong J.H., Lee C.L., Chou H.H., and et Chang T.C. Randomized trial of surgical staging (extraperitoneal or laparoscopic) versus clinical staging in locally advanced cervical cancer. Gynecol Oncol 89 (2003) 160-167
6. Winter R. Conservative surgery for microinvasive carcinoma of the cervix. J Obstet Gynaecol Res 24 6 (1998) 433-436
7. Nam J.-H., Kim S.-H., Kim J.-H., Kim Y.-T., and Mok J.-E. Nonradical treatment is as effective as radical surgery in the management of cervical cancer stage Ia1. Int J Gynecol Cancer 12 (2002) 480-484
8. Lu K.H., and Burke T.W. Early cervical cancer. Curr Treat Options Oncol 1 (2000) 147-155
9. Hacker N.F. Cervical cancer. In: Berek J.S., and Hacker N.F. (Eds). Practical gynecological oncology. 3rd ed. (2000), Lippincott Williams Wilkins, Sydney 345-405
10. Creasman W.T., Zaino R.J., Major F.J., DiSaia P.J., Hatch K.D., and Homesley H.P. Early invasive carcinoma of the cervix (3 to 5 mm invasion): risk factors and prognosis. A Gynecologic Oncology Group study. Am J Obstet Gynecol 178 1 Pt 1 (1998) 62-65
11. Landoni F., Maneo A., Colombo A., et al. Randomized study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 350 (1997) 535-540
12. Landoni F., Maneo A., Cormio G., et al. Class II versus Class III radical hysterectomy in stage Ib-IIa cervical cancer: a prospective randomized study. Gynecol Oncol 80 (2001) 3-12
13. Selman T.J., Luesley D.M., Murphy D.J., and Mann C.H. Is radical hysterectomy for early stage cervical cancer an outdated operation?. Br J Gynaecol 112 (2005) 363
14. Hoffman M.S. Extent of radical hysterectomy: evolving emphasis. Gynecol Oncol 94 (2004) 1-9
15. Steed H., Rosen B., Murphy J., Laframboise S., De Petrillo D., and Covens A. A comparison of laparoscopic-assisted radical vaginal hysterectomy and radical abdominal hysterectomy in the treatment of cervical cancer. Gynecol Oncol 93 (2004) 588-593
16. Plante M., Renaud M.C., Francois H., and Roy M. Vaginal radical trachelectomy: an oncologically safe fertility-preserving surgery. An updated series of 72 cases and review of the literature. Gynecol Oncol 94 (2004) 614-623
17. Angioli R., Estape R., Salom E., et al. Radical hysterectomy for cervical cancer: hysterectomy before pelvic lymphadenectomy or vice versa?. Int J Gynecol Cancer 9 (1999) 307-311
18. Sedlis A., Bundy B.N., and Rotman M.Z. A randomized trial of pelvic radiation versus no further therapy in selected patients with stage Ib cancer of the cervix after radical hysterectomy and pelvic lymphadenectomy. Gynecol Oncol 73 (1999) 177-183
19. Torne A., and Puig-Tintore L.M. The use of sentinel lymph nodes in gynaecological malignancies. Curr Opin Obstet Gynecol 16 (2004) 57-64
20. Angioli R., Palaia I., Cipriani C., et al. Role of sentinel lymph node biopsy procedure in cervical cancer: a critical point of view. Gynecol Oncol 96 (2005) 504-509
21. Denschlag D., Gabriel B., Mueller-Lantzsch C., et al. Evaluation of patients after extraperitoneal lymph node dissection for cervical cancer. Gynecol Oncol 96 (2005) 658-664
22. Kinney W.K., Alvarez R.D., and Reid G.C. Value of adjuvant whole pelvis irradiation after Wertheim hysterectomy for early stage squamous carcinoma of the cervix with pelvic nodal metastasis. A matched control study. Gynecol Oncol 34 (1989) 258-262
23. Stryker J.A., and Mortel R. Survival following extended field irradiation in carcinoma of cervix metastatic to para-aortic lymph nodes. Gynecol Oncol 79 (2000) 399-405
24. Varia M.A., Bundy B.N., Deppe G., et al. Cervical carcinoma metastatic to para-aortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: a Gynecologic Oncology Group study. Int J Radiat Oncol Biol Phys 42 (1998) 1015-1023
25. Sall S., Pineda A.A., Calanog A., Heller P., and Greenberg H. Surgical treatment of stage Ib and IIa invasive carcinoma of the cervix by radical hysterectomy. Am J Obstet Gynecol 135 (1979) 441-446
26. Lagasse L.D., Smith M.L., Moore J.G., et al. The effect of radiation therapy on pelvic lymph node involvement in stage I carcinoma of the cervix. Am J Obstet Gynecol 119 (1974) 328-343
27. Hacker N.F., Wain G.V., and Nicklin J.L. Resection of bulky positive lymph nodes in patients with cervical carcinoma. Int J Gynecol Cancer 5 (1995) 250-256
28. Kim P.Y., Monk B.J., Chabra S., et al. Cervical cancer with paraaortic metastases: significance of residual paraaortic disease after surgical staging. Gynecol Oncol 69 (1998) 243-247
29. Koh W.J., Panwala K., and Green B. Adjuvant therapy for high risk early stage cervical cancer. Semin Radiat Oncol 10 (2000) 51-60
30. Delgado G., Bundy B., Zaino R., et al. Prospective surgical-pathological study of disease-free interval in patients with stage Ib squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 38 (1990) 351-357
31. Ohara K., Tsunoda H., Nishida M., et al. Use of small pelvic field instead of whole pelvic field in postoperative radiotherapy for node-negative, high-risk stages I and II cervical squamous carcinoma. Int J Gynecol Cancer 13 (2003) 170-176
32. Panici P.B., Angioli R., Palaia I., et al. Tailoring the parametrectomy in stages IA2-IB1 cervical carcinoma: is it feasible and safe?. Gynecol Oncol 96 (2005) 792-798
33. Tierney J. Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials. Eur J Cancer 39 (2003) 2470-2486
34. Benedetti-Panici P., Greggi S., Colombo A., et al. Neoadjuvant chemotherapy and radical surgery versus exclusive surgery in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study. J Clin Oncol 20 (2002) 179-188
35. Tambaro R., Scambia G., Di Maio M., et al. The role of chemotherapy in locally advanced, metastatic and recurrent cervical cancer. Crit Rev Oncol Hematol 52 (2004) 33-44
36. Rose P.G., Bundy B.N., Watkins E.B., et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340 (1999) 1144-1153
37. Eiffel P.J., Winter K., Morris M., et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of Radiation Therapy Oncology Group (RTOG) 90-01. J Clin Oncol 22 (2004) 872-880
38. Green J.A., Kirwan J.M., Tierney J.F., et al. Survival recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 358 (2001) 781-786
39. Salom E.M., and Penalver M.A. Pelvic exenteration and reconstruction. Cancer J 9 (2003) 415-424
40. Hoeckel M. Laterally extended endopelvic resection. Novel surgical treatment of locally recurrent cervical carcinoma involving the pelvic side wall. Gynecol Oncol 91 (2003) 369-377
41. Vermorken J.B., and Eisenhauer E.A. Current developments in the treatment of cervical cancer. CME J Gynecol Oncol 6 (2001) 52-60
42. Long III H.J., Bundy B.N., Grendys E.C., et al. Randomized phase III trial of cisplatin vs cisplatin plus topotecan vs MVAC in stage IVb recurrent or persistent carcinoma of the uterine cervix. A Gynecologic Oncology Group Study. Proc SCO 35 (2004) 80 [abstract]